Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Reactive oxygen species (ROS) are a chemically diverse class of highly reactive molecules derived from molecular oxygen, including superoxide (O₂•⁻), hydrogen peroxide (H₂O₂), and hydroxyl radicals (•OH)[5]. They play fundamental roles in cellular signaling, immune defense, and metabolism, but excess ROS causes oxidative damage to proteins, nucleic acids, and lipids, contributing to aging and chronic disease[5][4][7]. Exposed protein sulfur atoms, primarily found in cysteine and methionine residues, are prime molecular targets for ROS. Oxidation of these sulfur-containing amino acids triggers important redox-regulated post-translational modifications (such as disulfide formation, S-glutathionylation, or sulfoxide formation), which can change protein activity, localization, or interactions—thereby modulating processes such as apoptosis, immune response, and cell proliferation[1][3][6]. Because the term "Reactive Oxygen Species / Exposed Protein Sulfur Atoms" refers to a chemical reactivity relationship rather than a molecular entity, it is not a single therapeutic target but a motif or class of redox-biochemistry interactions; thus, while relevant to disease and drug action, it does not map to a single gene, protein, or canonical therapeutic target[1][3][5][6].
Scavenging ROS to prevent protein and DNA damage - Modifying cysteine/methionine residues to alter protein function - Redox-dependent post-translational modification of target proteins (e.g., S-sulfenylation, S-nitrosylation, S-persulfidation) - Reversing oxidized sulfur atom modifications (e.g., via methionine sulfoxide reductase)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reactive oxygen species and exposed protein sulfur atoms (ROS (for Reactive oxygen species); no standard abbreviation for "exposed protein sulfur atoms").